ELAN (Elanco Animal Health) Other Current Receivables: $70 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ELAN Elanco Animal Health Inc ELAN
66 GF Score
Price $25.57
GF Value $15.60
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Elanco Animal Health Other Current Receivables?

Elanco Animal Health ELAN -1.01% 66 Other Current Receivables is $70 Mil as of Mar. 2026. GuruFocus rates ELAN with a GF Score™ of 66/100 and a GF Value™ of $15.60 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Elanco Animal Health's Other Current Receivables for the quarter that ended in Mar. 2026 was $70 Mil.

Elanco Animal Health's quarterly Other Current Receivables declined from Sep. 2025 ($81.00 Mil) to Dec. 2025 ($67.00 Mil) but then increased from Dec. 2025 ($67.00 Mil) to Mar. 2026 ($70.00 Mil).

Elanco Animal Health's annual Other Current Receivables declined from Dec. 2023 ($168.00 Mil) to Dec. 2024 ($81.00 Mil) and declined from Dec. 2024 ($81.00 Mil) to Dec. 2025 ($67.00 Mil).

Elanco Animal Health Other Current Receivables Related Terms

Elanco Animal Health Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Elanco Animal Health's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanco Animal Health Other Current Receivables Chart

Elanco Animal Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 195.00 205.00 168.00 81.00 67.00

Elanco Animal Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.00 114.00 81.00 67.00 70.00
ELAN
66GF Score
Elanco Animal Health Inc ELAN
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elanco Animal Health Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $70 Mil mean?
Elanco Animal Health (ELAN) has a Other Current Receivables of $70 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Elanco Animal Health and its competitors.
Is Elanco Animal Health's Other Current Receivables too high?
Elanco Animal Health's current Other Current Receivables is $70 Mil. Overall, Elanco Animal Health has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Elanco Animal Health's Other Current Receivables compare to ALKS and HIMS?
Elanco Animal Health's Other Current Receivables of $70 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Elanco Animal Health and its competitors. Elanco Animal Health's current Other Current Receivables is $70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elanco Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Elanco Animal Health (ELAN) is currently considered Significantly Overvalued. The stock's GF Value™ is $15.60, compared to a current price of $25.57 — trading 63.9% above its estimated fair value. The current Other Current Receivables is $70 Mil. Elanco Animal Health's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Elanco Animal Health (ELAN), the current Other Current Receivables is $70 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elanco Animal Health (ELAN) Overvalued in 2026?

Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued. The current stock price of $25.57 is trading 63.9% above its estimated GF Value™ of $15.60. GuruFocus considers Elanco Animal Health to be Significantly Overvalued.

Key valuation signals for ELAN:

  • Other Current Receivables: $70 Mil
  • GF Value™: $15.60 vs. price of $25.57 (63.9% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elanco Animal Health Business Description

Other Exchanges 5EA:Germany
Address 450 ELANCO CIRCLE, INDIANAPOLIS, IN, USA, 46221
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
66GF Score

Get the complete analysis for ELAN

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.57
Price
$15.60
GF Value